ABSTRACT
Objective Brain-computer interfaces (BCIs) can provide sensory feedback of ongoing brain oscillations enabling stroke survivors to modulate their sensorimotor rhythms purposefully. A number of recent clinical studies indicate that repeated use of such BCIs might trigger neurological recovery and hence improvement in motor function. Here we provide a first meta-analysis evaluating the clinical effectiveness of BCI-based post-stroke motor rehabilitation.
Methods Trials were identified using MEDLINE, CENTRAL, PEDro and by inspection of references in several review articles. We selected randomized controlled trials that used BCIs for post-stroke motor rehabilitation and provided motor impairment scores before and after the intervention. A random-effects inverse variance method was used to calculate the summary effect size.
Results We initially identified 524 articles and, after removing duplicates, we screened titles and abstracts of 473 articles. We found 26 articles corresponding to BCI clinical trials, of these, there were nine studies that involved a total of 235 post-stroke survivors fulfilling the inclusion criterion (randomized controlled trials that examined motor performance as an outcome measure) for the meta-analysis. Motor improvements, mostly quantified by the upper limb Fugl-Meyer Assessment (FMA-UE), exceeded the minimal clinical important difference (MCID=5.25) in six BCI studies, while such improvement was reached only in three control groups. Overall, the BCI training was associated with a standardized mean difference (SMD) of 0.79 (95% CI: 0.37 to 1.20) in FMA-UE compared to control conditions, which is in the range of medium to large summary effect size. In addition, several studies indicated BCI-induced functional and structural neuroplasticity at a sub-clinical level.
Interpretation We found a medium to large effect size of BCI therapy compared to controls. This suggests that BCI technology might be an effective intervention for post-stroke upper limb rehabilitation. However, more studies with larger sample size are required to increase the reliability of these results.
Footnotes
Declaration of interest: SRS received support from the European Commission under the project AIDE (645322), the Baden-Württemberg Stiftung (NEU007/1), the European Research Council (ERC) under the project NGBMI (759370), the Brain & Behavior Research Foundation as 2017 NARSAD Young Investigator Grant recipient and P&S Fund Investigator, JU and ML are supported by Japan Agency for Medical Research and Development (AMED). NB is supported by the Deutsche Forschungsgemeinschaft (DFG), Bundesministerium für Bildung und Forschung (BMBF, Motor-Bic, CoMiCom), EU Horizon 2020 (Luminous), Wyss Center for Bio and Neuroengeneering. JdRM received a grant from Wyss Center for Bio and Neuroengineering in Geneva. At the time of data collection and writing, MAC and GG were employees of MindMaze SA, Switzerland and NB was an employee of Wyss Center, Switzerland. JU and ML are collaborating with Panasonic Inc., Japan.